Document Type : Original article


1 Allergy Research Center, Mashhad University of Medical sciences, Mashhad, Iran

2 Pediatric Department, Mashhad University of Medical Sciences, Mashhad, Iran

3 mashhad, akbar hospital

4 1-Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran 2- Clinical Research Development Unit of Akbar Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran



Background: type 1 diabetes is one of the most chronic diseases of childhood. The therapeutic recommendation for this condition is quite complex and needs changes in lifestyle. Recently the role of gut microbiota has received attention as a possible mechanism in the pathogenesis and control of the disease.
Methods: One hundred thirty Children aged 6-18 years old with newly diagnosed diabetes type one participate in the trial. They are randomly assigned to the intervention or control group. The patients will receive a six month course of probiotics or placebo besides their conventional treatment with insulin and they will be followed for at least one year. Participants are followed at 3 month intervals for one year. At each visit anthropometrical data, glycemic control and total dose of insulin required to keep the optimal glycemic control is evaluated and registered.
Discussion: There is evidence that alterations in gut microbiota is seen in children with diabetes. In this study we aim to evaluate the effect of probiotic administration on the duration of honeymoon period in pediatrics with type one diabetes and their glycemic control and insulin requirements.